These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32538291)

  • 1. Involvement of CYP2D6 and CYP2B6 on tramadol pharmacokinetics.
    Saiz-Rodríguez M; Ochoa D; Román M; Zubiaur P; Koller D; Mejía G; Abad-Santos F
    Pharmacogenomics; 2020 Jul; 21(10):663-675. PubMed ID: 32538291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enantioselective pharmacokinetics of tramadol and its three main metabolites; impact of
    Haage P; Kronstrand R; Josefsson M; Calistri S; van Schaik RHN; Green H; Kugelberg FC
    Pharmacol Res Perspect; 2018 Jul; 6(4):e00419. PubMed ID: 29992026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetic aspects of tramadol pharmacokinetics and pharmacodynamics after a single oral dose.
    Bastami S; Haage P; Kronstrand R; Kugelberg FC; Zackrisson AL; Uppugunduri S
    Forensic Sci Int; 2014 May; 238():125-32. PubMed ID: 24709712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of fraction unbound, CYP3A, and CYP2D6 in vivo activities, and other potential covariates to the clearance of tramadol enantiomers in patients with neuropathic pain.
    de Moraes NV; Lauretti GR; Coelho EB; Godoy AL; Neves DV; Lanchote VL
    Fundam Clin Pharmacol; 2016 Apr; 30(2):153-61. PubMed ID: 26947771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of CYP2D6 and CYP2B6 phenotypes on the response to tramadol in patients with acute post-surgical pain.
    Casajús A; Zubiaur P; Alday E; Soria-Chacartegui P; Saiz-Rodríguez M; Gutierrez L; Aragonés C; Campodónico D; Gómez-Fernández A; Navares-Gómez M; Villapalos-García G; Mejía-Abril G; Ochoa D; Abad-Santos F
    Clin Transl Sci; 2024 Jan; 17(1):e13698. PubMed ID: 38140786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of CYP2D6, CYP3A4, CYP3A5 and ABCB1 Polymorphisms on Pharmacokinetics and Safety of Aripiprazole in Healthy Volunteers.
    Belmonte C; Ochoa D; Román M; Saiz-Rodríguez M; Wojnicz A; Gómez-Sánchez CI; Martín-Vílchez S; Abad-Santos F
    Basic Clin Pharmacol Toxicol; 2018 Jun; 122(6):596-605. PubMed ID: 29325225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of terbinafine and itraconazole on the pharmacokinetics of orally administered tramadol.
    Saarikoski T; Saari TI; Hagelberg NM; Backman JT; Neuvonen PJ; Scheinin M; Olkkola KT; Laine K
    Eur J Clin Pharmacol; 2015 Mar; 71(3):321-7. PubMed ID: 25560051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of tramadol enantiomers and their respective phase I metabolites in relation to CYP2D6 phenotype.
    García-Quetglas E; Azanza JR; Sádaba B; Muñoz MJ; Gil I; Campanero MA
    Pharmacol Res; 2007 Feb; 55(2):122-30. PubMed ID: 17175164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy.
    Crews KR; Monte AA; Huddart R; Caudle KE; Kharasch ED; Gaedigk A; Dunnenberger HM; Leeder JS; Callaghan JT; Samer CF; Klein TE; Haidar CE; Van Driest SL; Ruano G; Sangkuhl K; Cavallari LH; Müller DJ; Prows CA; Nagy M; Somogyi AA; Skaar TC
    Clin Pharmacol Ther; 2021 Oct; 110(4):888-896. PubMed ID: 33387367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms associated with fentanyl pharmacokinetics, pharmacodynamics and adverse effects.
    Saiz-Rodríguez M; Ochoa D; Herrador C; Belmonte C; Román M; Alday E; Koller D; Zubiaur P; Mejía G; Hernández-Martínez M; Abad-Santos F
    Basic Clin Pharmacol Toxicol; 2019 Mar; 124(3):321-329. PubMed ID: 30281924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of CYP2D6 genetic polymorphisms and the pharmacokinetics of tramadol in Chinese volunteers.
    Li Q; Wang R; Guo Y; Wen S; Xu L; Wang S
    J Clin Pharm Ther; 2010 Apr; 35(2):239-47. PubMed ID: 20456744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the cytochrome P450 2D6*10 genotype on the pharmacokinetics of tramadol in post-operative patients.
    Xu J; Zhang XC; Lv XQ; Xu YY; Wang GX; Jiang B; Cai L; Cai XJ
    Pharmazie; 2014 Feb; 69(2):138-41. PubMed ID: 24640604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of CYP2D6 genetic polymorphism on tramadol pharmacokinetics and pharmacodynamics.
    Gan SH; Ismail R; Wan Adnan WA; Zulmi W
    Mol Diagn Ther; 2007; 11(3):171-81. PubMed ID: 17570739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Massive tramadol ingestion resulting in fatal brain injury - a pharmacokinetic study with discussion on the involved mechanisms of toxicity.
    Puszkiel A; Malissin I; Cisternino S; Pallet N; Declèves X; Mégarbane B
    Clin Toxicol (Phila); 2022 Sep; 60(9):1059-1062. PubMed ID: 35506822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pathway-driven predictive model of tramadol pharmacogenetics.
    Wendt FR; Novroski NMM; Rahikainen AL; Sajantila A; Budowle B
    Eur J Hum Genet; 2019 Jul; 27(7):1143-1156. PubMed ID: 30824817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP2D6 polymorphism in relation to tramadol metabolism: a study of faroese patients.
    Halling J; Weihe P; Brosen K
    Ther Drug Monit; 2008 Jun; 30(3):271-5. PubMed ID: 18520597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of CYP genotype and inflammatory markers on the plasma concentrations of tramadol and its demethylated metabolites and drug tolerability in cancer patients.
    Tanaka H; Naito T; Sato H; Hiraide T; Yamada Y; Kawakami J
    Eur J Clin Pharmacol; 2018 Nov; 74(11):1461-1469. PubMed ID: 30051214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone.
    Samer CF; Daali Y; Wagner M; Hopfgartner G; Eap CB; Rebsamen MC; Rossier MF; Hochstrasser D; Dayer P; Desmeules JA
    Br J Pharmacol; 2010 Jun; 160(4):907-18. PubMed ID: 20590587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A logistic equation to determine the validity of tramadol from related gene polymorphisms and psychological factors.
    Zhao Q; Sun J; Tao Y; Wang S; Jiang C; Zhu Y; Yu F; Zhu J
    Pharmacogenomics; 2014 Mar; 15(4):487-95. PubMed ID: 24624916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotypic screening of the main opiate-related polymorphisms in a cohort of 139 sickle cell disease patients.
    Joly P; Gagnieu MC; Bardel C; Francina A; Pondarre C; Martin C
    Am J Hematol; 2012 May; 87(5):534-6. PubMed ID: 22430884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.